David E Lerner

US Patent:

6713074, Mar 30, 2004

Filed:

Jun 29, 2001

Appl. No.:

09/896566

Inventors:

David S. Lerner - Boca Raton FL
Gregory Schultz - Gainesville FL

Assignee:

Quick Med Technologies Inc. - Gainesville FL
University of Florida Research Foundation, Inc. - Gainesville FL

International Classification:

A61K 700

US Classification:

424401, 424 59, 514 23, 514 24, 514 25, 514 26, 514 33, 514182

Abstract:

The cosmetic topical formulation of this invention is directed toward diminishing skin wrinkling, fine line, improving skin tone, and combinations thereof. Preferably, the topical formulation contains a matrix metalloproteinase inhibitor, MMPI, and advantageously includes a natural estrogen, e. g. , a true estrogen compound, such as 17-beta estradiol, or an estrogen-like steroid, (such as various phytoestrogens found in herbal preparations), as opposed to a synthetic estrogen. Other forms of the cosmetic topical formulation of this invention include combinations of synthetic estrogen and MMP inhibitor. Exemplary synthetic estrogens include, but are not limited to, ethinyl estradiol and clomiphine citrate. The cosmetic topical formulation is safe and effective diminishing wrinkling, and improving skin tone. Certain compositions of this invention are useful for minimizing photodamage to skin, while in other embodiments, the composition according to this invention is useful to prevent or minimize the adverse effects on skin induced by cigarette smoking.

US Patent:

7045673, May 16, 2006

Filed:

Dec 8, 1999

Appl. No.:

09/857906

Inventors:

Christopher D. Batich - Gainesville FL, US
Bruce A Mast - Gainesville FL, US
Gregory Schultz - Gainesville FL, US
Gerald M. Olderman - New Bedford MA, US
David S. Lerner - Boca Raton FL, US

Assignee:

Quick-Med Technologies, Inc. - Gainesville FL
University of Florida Research Foundation, Inc. - Gainesville FL

International Classification:

A61F 13/00

US Classification:

602 48, 602 42, 602 43, 424443, 424447

Abstract:

Absorbent dressings, including highly-absorbent dressings having antimicrobial polymer attached thereto via non-siloxane bonds are disclosed. Bandages (i. e. wound dressing), sanitary napkins and the like are useful applications for the intrinsically bactericidal absorbent dressings whose method of manufacture and use are disclosed and claimed.

US Patent:

7709694, May 4, 2010

Filed:

Sep 28, 2001

Appl. No.:

09/965740

Inventors:

Christopher D. Batich - Gainesville FL, US
Gregory Schultz - Gainesville FL, US
Bruce A. Mast - Gainesville FL, US
Gerald M. Olderman - New Bedford MA, US
David S. Lerner - Boca Raton FL, US
William Toreki - Gainesville FL, US

Assignee:

Quick-Med Technologies, Inc. - Gainesville FL
University of Florida Research Foundation, Inc. - Gainesville FL

International Classification:

A61F 13/00

US Classification:

604360, 602 48, 427 231

Abstract:

This invention relates to methods and compositions for materials having a non-leaching coating that has antimicrobial properties. The coating is applied to substrates such as gauze-type wound dressings. Covalent, non-leaching, non-hydrolyzable bonds are formed between the substrate and the polymer molecules that form the coating. A high concentration of anti-microbial groups on multi-length polymer chains and relatively long average chain lengths, contribute to an absorbent or superabsorbent surface with a high level antimicrobial effect.

US Patent:

20020032904, Mar 14, 2002

Filed:

May 25, 2001

Appl. No.:

09/865319

Inventors:

David Lerner - Boca Raton FL, US

International Classification:

H04N007/173
H04N007/16

US Classification:

725/014000, 725/134000, 725/110000

Abstract:

The present invention relates to a system and method for collecting and transmitting data concerning the viewing habits of a viewer. The present invention instantaneously records the data concerning the viewing habits of the viewer while he or she watches programming on a television or streaming media on a conventional personal computer (PC) monitor.

US Patent:

20030083321, May 1, 2003

Filed:

Sep 25, 2002

Appl. No.:

10/256215

Inventors:

David Lerner - Boca Raton FL, US
Gregory Schultz - Gainesville FL, US

International Classification:

A61K031/56

US Classification:

514/171000

Abstract:

The invention pertains to compositions and methods to treat the adverse effects of mustard chemicals and other toxic compounds, such as chemical warfare agents, exposure to which normally induces vesicating type response in mammals. In a rodent eye model at fixed concentrations of such a vesicant, compositions comprising (a) a matrix metalloproteinase inhibitor, MMPI, and (b) a protease inhibitor, PI, such as a serine protease inhibitor, SPI, a significant reduction in morbidity is achieved with increased concentrations of the compositions of this invention, as compared with an MMPI inhibitor alone or vehicle alone. Furthermore, compositions comprising the MMPI, the SPI, and in addition, an anti-inflammatory compound, in a vehicle appropriate to the type of tissue damage to be protected against from vesicant exposure, achieves both reduction in total tissue damage and inflammation, as compared with anti-inflammatory composition alone. Chemicals having more than one property, such as MMPI and AIA properties, are also disclosed. Certain combinations disclosed are applied to treat injuries due to acids and bases.

US Patent:

20040185127, Sep 23, 2004

Filed:

Mar 1, 2004

Appl. No.:

10/790386

Inventors:

David Lerner - Boca Raton FL, US

International Classification:

A61K035/78
A61K007/42

US Classification:

424/764000, 514/033000, 424/059000

Abstract:

The cosmetic topical formulation of this invention is directed toward diminishing skin wrinkling, fine line, improving skin tone, and combinations thereof. Preferably, the topical formulation contains a matrix metalloproteinase inhibitor, MMPI, and advantageously includes a natural estrogen, e.g., a true estrogen compound, such as 17-beta estradiol, or an estrogen-like steroid, (such as various phytoestrogens found in herbal preparations), as opposed to a synthetic estrogen. Other forms of the cosmetic topical formulation of this invention include combinations of synthetic estrogen and MMP inhibitor. Exemplary synthetic estrogens include, but are not limited to, ethinyl estradiol and clomiphine citrate. The cosmetic topical formulation is safe and effective diminishing wrinkling, and improving skin tone. Certain compositions of this invention are useful for minimizing photodamage to skin, while in other embodiments, the composition according to this invention is useful to prevent or minimize the adverse effects on skin induced by cigarette smoking.

US Patent:

46462015, Feb 24, 1987

Filed:

Dec 14, 1984

Appl. No.:

6/681936

Inventors:

David R. Lerner - Mount Vernon NY

International Classification:

H02B 110

US Classification:

361377

Abstract:

An ultrahighlight fluorescent light mounting system for filming, particularly in color. A head carries the fluorescent tubes and a removable light shield while the ballast is positioned in a container remote from the head. The head is set upon and swivable about an upper post, which is rotatably connected to a lower post, which in turn is set upon and swivable about a swivel piece extending from a standard stand. The head, light shield, first post, second post, stand, and ballast can all be dissembled from one another and placed in carrying cases.

US Patent:

46330097, Dec 30, 1986

Filed:

Jun 18, 1985

Appl. No.:

6/745894

Inventors:

David I. Lerner - Teaneck NJ

Assignee:

Frizsche Dodge & Olcott Inc. - New York NY

International Classification:

C07C10154

US Classification:

560 19

Abstract:

Methyl N-methylanthranilate is prepared by reductive alkylation of methylanthranilate with formaldehyde and hydrogen in the presence of a hydrogenation catalyst and an acid catalyst.